Skip to content
AdvanDx logo — company profile

AdvanDx

Founded 2002 United States Woburn, United States 17 employees Debt Financing Biotechnology, Health Care +1

General Information

Company Name AdvanDx
Founded Year 2002
Location United States Woburn, United States
Employees 17
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with AdvanDx. To contact AdvanDx, visit advandx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AdvanDx compare?

A PDF of AdvanDx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AdvanDx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AdvanDx

AdvanDx is a prominent player in the biotechnology, healthcare, and medical devices industries, specializing in rapid and accurate molecular diagnostic tests for identifying pathogens causing critical infections in hospitalized patients. Founded in 2002 and headquartered in the United States, AdvanDx is dedicated to improving antibiotic decision-making, patient outcomes, and reducing unnecessary antibiotic use and costs. The company's unique approach, Whole Cell Analysis (WCA), utilizes its proprietary Peptide Nucleic Acid Fluorescence In Situ Hybridization (PNA FISH) technology platform. This technology enables fast and highly accurate single cell analysis for bacterial species identification in patient samples with critical infections. AdvanDx is a market leader in molecular testing of positive blood cultures, allowing clinical microbiology labs to provide pathogen identification results 48 to 72 hours earlier than conventional testing methods. AdvanDx's PNA FISH® tests have demonstrated their significance in clinical studies by reducing patient mortality, shortening the length of stay, and lowering hospital costs through ensuring early, appropriate antibiotic therapy for patients with bloodstream infections (septicemia). The company secured a Debt Financing investment on 17th March 2015, showcasing investor confidence in its innovative solutions for improving patient care and healthcare system efficiency.

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Undisclosed -
17 Mar 2015
Venture Series Unknown Undisclosed -
08 Apr 2014
Venture Series Unknown Undisclosed -
29 Oct 2012
Series C Undisclosed -
12 Oct 2009
Series C Undisclosed -
18 Sep 2007
Series B Undisclosed -
08 May 2006
Series B Undisclosed -
24 Nov 2003

AdvanDx Alternatives & Competitors

AdvanDx vs

MicrobeDx is a molecular diagnostics company that seeks to revolutionize clinical microbiology. Over...

Seed
3 employees
Biotechnology, Health Care
AdvanDx vs

The future of infectious disease diagnostics starts at Day Zero.

64 employees
Biotechnology, Health Care

FAQ About AdvanDx

AdvanDx is a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens that cause critical infections in hospitalized patients. Our mission is to improve antibiotic decision-making and patient outcomes while limiting unnecessary antibiotic use and reducing cos...
AdvanDx was founded in 2002.
AdvanDx is headquartered in Woburn, United States.
AdvanDx operates in Biotechnology, Health Care and Medical Devices.
AdvanDx has approximately 17 employees.
AdvanDx has completed 7 funding rounds. The latest funding stage is Debt Financing.
Top alternatives and competitors to AdvanDx include MicrobeDx, Day Zero Diagnostics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AdvanDx and MicrobeDx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AdvanDx, https://bouncewatch.com/company/advandx, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout